In a MedCityNews article, Avalon’s CEO Bill Kerr, M.D., highlights how ensuring every test within a panel has clinical significance can move us toward value-based care. Panel stuffing occurs when tests without clinical value are added to commonly ordered panels.
Read more by visiting MedCityNews.